NovoCure Limited Contract Liability (Deferred Revenue)
NovoCure Limited (NVCR) had Contract Liability (Deferred Revenue) of $16.87 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-07-23
- 2026-06-30: Contract with Customer, Liability, Current $16.87M.
- 2026-03-31: Contract with Customer, Liability, Current $15.91M.
- 2025-12-31: Contract with Customer, Liability, Current $15.95M.
- 2025-09-30: Contract with Customer, Liability, Current $15.70M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $16.87M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $15.91M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $15.95M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $15.70M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $15.35M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $14.75M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $14.22M 10-K · filed 2026-02-26 |
| 2024-09-30 | $14.87M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $15.61M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $15.87M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $16.22M 10-K · filed 2025-02-27 |
| 2022-12-31 | $18.03M 10-K · filed 2024-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |